Vericel Corp.

Vericel Corp.
Stock Exchange NASDAQ Stock Market
EPS
$0.1
Market Cap
$832.55 M
Shares Outstanding
43.91 M
Public Float
43.44 M

Profile

Address
64 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.vcel.com
Updated 07/08/2019
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies to repair and regenerate damaged tissues and organs to normal structure and function. Its product portfolio include MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee.

Financials

View All

Dominick C. Colangelo
President, Chief Executive Officer & Director
Robert L. Zerbe
Chairman